Mazor Robotics to Report Fourth Quarter and Full Year 2013 Financial Results on February 25, 2014
[ Back ]   [ More News ]   [ Home ]
Mazor Robotics to Report Fourth Quarter and Full Year 2013 Financial Results on February 25, 2014

CAESAREA, Israel — (BUSINESS WIRE) — January 30, 2014 — Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it will report financial results for the fourth quarter and year ended December 31, 2013, before the U.S. markets open on Tuesday, February 25, 2014.

The company will host a conference call to discuss these results on Tuesday, February 25, 2014, at 8:30 AM ET (3:30 PM IST). Investors within the United States interested in participating are invited to call 877-941-0844 and reference the Conference ID: 466572. Participants in Israel can use the toll free dial-in number 1809-21-4368 and reference the same Conference ID number. All other international participants can use the dial-in number 1-480-629-9765, using the same Conference ID.

A replay of the event will be available for two weeks following the conclusion of the call. To access the replay, callers in the United States can call 1-800-406-7325 and reference the Replay Access Code: 4665722. All international callers can dial 1-30-590-3030, using the same Replay Access Code. To access the webcast, please visit www.mazorrobotics.com, click ‘Investors.’

About Mazor

Mazor Robotics is dedicated to the development and marketing of innovative surgical guidance system and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical Guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 35,000 implants worldwide. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, the content of which is not part of this press release, please visit www.mazorrobotics.com.



Contact:

U.S. Contacts: EVC Group
Michael Polyviou, 212-850-6020 (Investors)
Email Contact
Robert Jones, 646-201-5447 (Investors)
Email Contact
John Carter, 212-850-6021 (Media)
Email Contact